Overall (2078) | Baseline plasma potassium (mmol/L) | p | |||
---|---|---|---|---|---|
<4 (n = 566) | 4–5 (n = 1340) | >5 (n = 172) | |||
Demographics | |||||
Age (years) | 58.8 ± 15.2 | 56.0 ± 15.6 | 60.2 ± 14.8 | 56.9 ± 15.5 | <.001 |
Men (%) | 66.3 | 60.7 | 67.9 | 72.7 | <.001 |
African (%) | 13.0 | 18.0 | 11.0 | 12.2 | <.001 |
BMI (kg/m2) | 26.6 ± 5.2 | 26.2 ± 5.4 | 26.8 ± 5.1 | 26.5 ± 5.2 | 0.20 |
Former smokers (%) | 30.9 | 25.4 | 33.2 | 30.8 | <.001 |
Current smokers (%) | 13.7 | 12.4 | 13.4 | 20.3 | |
Clinics | |||||
CVD history (%) | 17.3 | 10.9 | 19.9 | 18.6 | <.001 |
Diabetes (%) | 29.9 | 25.6 | 30.9 | 37.2 | 0.01 |
Primary kidney disease (%) | <.001 | ||||
Diabetic | 10.1 | 5.1 | 11.1 | 18.6 | |
Glomerular | 14.1 | 12.4 | 14.3 | 18.6 | |
Vascular | 26.2 | 26.5 | 26.4 | 23.3 | |
Polycystic | 5.5 | 9.0 | 4.3 | 3.5 | |
Interstitial | 9.0 | 9.9 | 8.8 | 7.6 | |
Other or unknown | 35.0 | 37.1 | 35.0 | 28.5 | |
Measurements | |||||
Systolic BP (mm Hg) | 136.0 ± 20.4 | 134.7 ± 20.7 | 136.2 ± 20.8 | 138.8 ± 21.4 | 0.07 |
Diastolic BP (mm Hg) | 74.8 ± 11.6 | 75.5 ± 12.2 | 74.5 ± 11.5 | 76.1 ± 10.3 | 0.13 |
Mean BP (mmHg) | 95.3 ± 13.3 | 95.3 ± 14 | 95.0 ± 13.0 | 97.0 ± 12.6 | 0.48 |
mGFR (ml/min/1.73m2) | 38.9 (27.2–53.8) | 47.9 (35.7–64.2) | 37.6 (26.7–51.7) | 24.7 (16.4–34.3) | <.001 |
Albuminemia (g/L) | 39.4 ± 4.5 | 39.4 ± 4.2 | 39.4 ± 4.5 | 39.3 ± 5.2 | 0.72 |
Albumin/creatinine ratio | 8.9 (1.6–50.9) | 5.4 (1.4–31.7) | 9.6 (1.5–54.7) | 28.0 (6.0–98.2) | <.001 |
Plasma potassium (mmol/L) | 4.3 ± 0.5 | 3.7 ± 0.2 | 4.4 ± 0.3 | 5.3 ± 0.4 | – |
Urinary potassium (mmol/24 h) | 66.0 ± 35.1 | 64.1 ± 31 | 62 ± 26.1 | 62 ± 26.1 | 0.10 |
Medication use | |||||
ACEi or ARBs (%) | 74.4 | 65.7 | 76.5 | 86.1 | <.001 |
β-blockers (%) | 37.3 | 32.5 | 39.3 | 38.4 | 0.02 |
Bicarbonate (%) | 3.8 | 1.6 | 4.1 | 7.6 | <.001 |
Potassium-binding resins (%) | 6.6 | 2.3 | 7.2 | 16.9 | <.001 |
Potassium non-sparing diureticsa(%) | 46.7 | 48.2 | 45.6 | 50.6 | 0.08 |
Potassium-sparing diureticsb (%) | 3.4 | 4.4 | 3.0 | 2.9 | 0.31 |